DRIO (DarioHealth) FFO per Share


DRIO DarioHealth Corp DRIO
57 GF Score
Price $7.22
GF Value $7.04
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is DarioHealth FFO per Share?

FFO per Share only applies to REITs.

DRIO
57GF Score
DarioHealth Corp DRIO
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DarioHealth (DRIO) Overvalued in 2026?

Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued. The current stock price of $7.22 is trading 2.6% above its estimated GF Value™ of $7.04. GuruFocus considers DarioHealth to be Fairly Valued.

Key valuation signals for DRIO:

  • FFO per Share:
  • GF Value™: $7.04 vs. price of $7.22 (2.6% above fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DarioHealth Business Description

Address 322 West 57th Street, New York, NY, USA, 10019
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
57GF Score

Get the complete analysis for DRIO

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.22
Price
$7.04
GF Value